GE; Min

Patent Applications and Registrations

Patent applications and USPTO patent grants for GE; Min.The latest application filed is for "zea mays nlp transcription factor zmnlp5 and use thereof".

Company Profile

1.9.14

GE; Min - Nanjing CN
GE; Min - Beijing CN
Ge; Min - Edison NJ
Ge; Min - Prineton NJ
Ge; Min - Princeton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Zea Mays Nlp Transcription Factor Zmnlp5 And Use Thereof App 20200347398 - GE; Min ; et al.	2020-11-05
Vancomycin derivative, and preparation method and application thereof Grant 9,828,413 - Ge November 28, 2	2017-11-28
Polymetallocarbosilane From Organic Metal Catalyzed Polymerization And Uses Thereof App 20170088674 - ZHANG; Weigang ; et al.	2017-03-30
Vancomycin Derivative, And Preparation Method And Application Thereof App 20160200768 - GE; Min	2016-07-14
Antidiabetic bicyclic compounds Grant 8,039,484 - Ge , et al. October 18, 2	2011-10-18
Antidiabetic bicyclic compounds Grant 7,759,493 - Ge , et al. July 20, 2	2010-07-20
Antidiabetic Bicyclic Compounds App 20100105725 - Ge; Min ; et al.	2010-04-29
Antidiabetic Bicyclic Compounds App 20090312303 - Ge; Min ; et al.	2009-12-17
Substituted Pyrazoles as Ghrelin Receptor Antagonists App 20090253673 - Ge; Min ; et al.	2009-10-08
Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same Grant 7,473,671 - Kahne , et al. January 6, 2	2009-01-06
Antidiabetic bicyclic compounds Grant 7,442,808 - Ge , et al. October 28, 2	2008-10-28
Process for the preparation of CCR-2 antagonists Grant 7,361,765 - Cai , et al. April 22, 2	2008-04-22
Antidiabetic Bicyclic Compounds App 20080090865 - Ge; Min ; et al.	2008-04-17
Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same Grant 7,331,920 - Kahne , et al. February 19, 2	2008-02-19
Antidiabetic bicyclic compounds App 20070265332 - Ge; Min ; et al.	2007-11-15
Process for the preparation of ccr-2 antagonists App 20070135475 - Cai; Dongwei ; et al.	2007-06-14
7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity App 20060183731 - Ge; Min ; et al.	2006-08-17
Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same App 20050075483 - Kahne, Daniel ; et al.	2005-04-07
Substrate analog for murg, methods of making same and assays using same App 20040180813 - Kahne, Suzanne Walker ; et al.	2004-09-16
Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same App 20040106772 - Kahne, Daniel ; et al.	2004-06-03
Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same Grant 6,710,168 - Kahne , et al. March 23, 2	2004-03-23
Substrate analogs for MurG, methods of making same and assays using same Grant 6,703,213 - Kahne , et al. March 9, 2	2004-03-09
Substrate analogs for MurG, methods of making same and assays using same App 20020182661 - Kahne, Suzanne Walker ; et al.	2002-12-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.